216 related articles for article (PubMed ID: 28295319)
1. Preparation, pharmacokinetics and tumour-suppressive activity of berberine liposomes.
Wang X; Wang Q; Liu Z; Zheng X
J Pharm Pharmacol; 2017 Jun; 69(6):625-632. PubMed ID: 28295319
[TBL] [Abstract][Full Text] [Related]
2. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
[TBL] [Abstract][Full Text] [Related]
3. Approaches to improve the oral bioavailability and effects of novel anticancer drugs berberine and betulinic acid.
Godugu C; Patel AR; Doddapaneni R; Somagoni J; Singh M
PLoS One; 2014; 9(3):e89919. PubMed ID: 24614362
[TBL] [Abstract][Full Text] [Related]
4. Dual-functional Brij-S20-modified nanocrystal formulation enhances the intestinal transport and oral bioavailability of berberine.
Xiong W; Sang W; Linghu KG; Zhong ZF; Cheang WS; Li J; Hu YJ; Yu H; Wang YT
Int J Nanomedicine; 2018; 13():3781-3793. PubMed ID: 29988733
[TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacokinetics and safety assessment of transdermal berberine and dihydroberberine.
Buchanan B; Meng Q; Poulin MM; Zuccolo J; Azike CG; Gabriele J; Baranowski DC
PLoS One; 2018; 13(3):e0194979. PubMed ID: 29579096
[TBL] [Abstract][Full Text] [Related]
6. PEG-coated irinotecan cationic liposomes improve the therapeutic efficacy of breast cancer in animals.
Zhang L; Cao DY; Wang J; Xiang B; Dun JN; Fang Y; Xue GQ
Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3347-61. PubMed ID: 24379067
[TBL] [Abstract][Full Text] [Related]
7. Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles.
Xue M; Yang MX; Zhang W; Li XM; Gao DH; Ou ZM; Li ZP; Liu SH; Li XJ; Yang SY
Int J Nanomedicine; 2013; 8():4677-87. PubMed ID: 24353417
[TBL] [Abstract][Full Text] [Related]
8. [In vivo imaging in tumor-bearing animals and pharmacokinetics of PEGylated liposomes modified with RGD cyclopeptide].
Tu LX; Xu YH; Tang CY; Deng LH; Wu CB
Yao Xue Xue Bao; 2012 May; 47(5):646-51. PubMed ID: 22812011
[TBL] [Abstract][Full Text] [Related]
9. Berberine-loaded liposomes for oral delivery: Preparation, physicochemical characterization and in-vivo evaluation in an endogenous hyperlipidemic animal model.
Duong TT; Yen TTH; Nguyen LT; Nguyen TD; Nguyen TQ; Nghiem TH; Pham HT; Raal A; Heinämäki J; Pham TM
Int J Pharm; 2022 Mar; 616():121525. PubMed ID: 35104597
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study of pharmacokinetics and tissue distribution of 8-cetylberberine and berberine in rats].
Hu YL; Chen C; Zou ZY; Li XG; Ye XL
Yao Xue Xue Bao; 2014 Nov; 49(11):1582-7. PubMed ID: 25757286
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic studies of novel berberine derivatives with ultra-performance liquid chromatography-tandem mass spectrometry.
Wang W; Shen Q; Liang H; Hua C; Liu Y; Li F; Li Q
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Sep; 1031():172-180. PubMed ID: 27494281
[TBL] [Abstract][Full Text] [Related]
12. Drug-drug interactions between ketoconazole and berberine in rats: pharmacokinetic effects benefit pharmacodynamic synergism.
Zhou Y; He P; Liu A; Zhang L; Liu Y; Dai R
Phytother Res; 2012 May; 26(5):772-7. PubMed ID: 22114028
[TBL] [Abstract][Full Text] [Related]
13. Berberine encapsulated PEG-coated liposomes attenuate Wnt1/β-catenin signaling in rheumatoid arthritis via miR-23a activation.
Sujitha S; Dinesh P; Rasool M
Eur J Pharm Biopharm; 2020 Apr; 149():170-191. PubMed ID: 32068029
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic interactions between metformin and berberine in rats: Role of oral administration sequences and microbiota.
Lyu Y; Zhang Y; Yang M; Lin L; Yang X; Cheung SCK; Shaw PC; Chan PKS; Kong APS; Zuo Z
Life Sci; 2019 Oct; 235():116818. PubMed ID: 31473193
[TBL] [Abstract][Full Text] [Related]
15. Improvement of intestinal transport, absorption and anti-diabetic efficacy of berberine by using Gelucire44/14: In vitro, in situ and in vivo studies.
Sun J; Bao H; Peng Y; Zhang H; Sun Y; Qi J; Zhang H; Gao Y
Int J Pharm; 2018 Jun; 544(1):46-54. PubMed ID: 29654898
[TBL] [Abstract][Full Text] [Related]
16. Nanoformulation and Evaluation of Oral Berberine-Loaded Liposomes.
Duong TT; Isomäki A; Paaver U; Laidmäe I; Tõnisoo A; Yen TTH; Kogermann K; Raal A; Heinämäki J; Pham TM
Molecules; 2021 Apr; 26(9):. PubMed ID: 33946815
[TBL] [Abstract][Full Text] [Related]
17. A near-infrared two-photon-sensitive peptide-mediated liposomal delivery system.
Yang Y; Yang Y; Xie X; Cai X; Wang Z; Gong W; Zhang H; Li Y; Mei X
Colloids Surf B Biointerfaces; 2015 Apr; 128():427-438. PubMed ID: 25766920
[TBL] [Abstract][Full Text] [Related]
18. MgAl monolayer hydrotalcite increases the hypoglycemic effect of berberine by enhancing its oral bioavailability.
Wang A; Yang W; Yang X; Mei X; Hu T; Liang R; Meng D; Yan D
Biomed Pharmacother; 2020 Jul; 127():110140. PubMed ID: 32380387
[TBL] [Abstract][Full Text] [Related]
19. Research progress on berberine with a special focus on its oral bioavailability.
Liu CS; Zheng YR; Zhang YF; Long XY
Fitoterapia; 2016 Mar; 109():274-82. PubMed ID: 26851175
[TBL] [Abstract][Full Text] [Related]
20. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y
J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
